[go: up one dir, main page]

WO2001022915A2 - Process for production of cis-dichloro-(trans-1-1,2-cyclohexanediamine)platinum(ii) - Google Patents

Process for production of cis-dichloro-(trans-1-1,2-cyclohexanediamine)platinum(ii) Download PDF

Info

Publication number
WO2001022915A2
WO2001022915A2 PCT/CZ2000/000070 CZ0000070W WO0122915A2 WO 2001022915 A2 WO2001022915 A2 WO 2001022915A2 CZ 0000070 W CZ0000070 W CZ 0000070W WO 0122915 A2 WO0122915 A2 WO 0122915A2
Authority
WO
WIPO (PCT)
Prior art keywords
alkali metal
tetrachloroplatinate
aqueous solution
trans
platinum
Prior art date
Application number
PCT/CZ2000/000070
Other languages
French (fr)
Other versions
WO2001022915A3 (en
Inventor
František ŽÁK
Anna Poulová
Original Assignee
Pliva-Lachema A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva-Lachema A.S. filed Critical Pliva-Lachema A.S.
Priority to AU72673/00A priority Critical patent/AU7267300A/en
Publication of WO2001022915A2 publication Critical patent/WO2001022915A2/en
Publication of WO2001022915A3 publication Critical patent/WO2001022915A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage

Definitions

  • the invention deals with a new process for production of an antitumor effective compound c/5-dichloro-(tr ⁇ «5-/-l,2-cyclohexanediamine)platinum(II) complex of the formula
  • the goal of the present invention is to find a new process for preparation of the cis- dichloro-(tra «5-/-l,2-cyclohexanediamine)platinum(II) which would not suffer from the above disadvantages.
  • 1 molar equivalent of an alkali metal salt of tetrachloroplatinate(II) is treated with 1.1 to 1.3 molar equivalents of tr «5-/-l,2-cyclohexanediammonium tartrate.
  • the alkalinity of the reaction mixture is maintained during the reaction by additions of an alkali metal hydroxide within the pH range from 8 to 11.
  • the aqueous suspension of tr ⁇ «s-/-l,2-cyclohexanediammonium tartrate is first alkalinized by an alkali metal hydroxide to a pH value higher than 8 and , prior to mixing with the aqueous solution of alkali metal tetrachloroplatinate(II), the obtained solution is separated from insoluble impurities present.
  • a raw aqueous solution of potassium tetrachloroplatinate(II) obtained by reduction of potassium hexachloroplatinate(IV) by hydrazinium dichloride, separation of insoluble parts and neutralisation of the free hydrochloric acid present in the obtained aqueous solution by an alkali metal hydroxide may advantageously be used .
  • Reaction temperature is not a critical parameter within the process of the invention.
  • the obtained c/s-dicMoro-(tr ⁇ «s-/-l,2-cyclohexanediamine)platinum(II) may be separated from the reaction mixture by standard separation techniques, washed with a diluted hydrochloric acid and/or by water and/or by a water miscible organic solvent, advantageously by a low boiling alcohol, and optionally also by ether, and subsequently dried.
  • the optically active tr ⁇ «5-/-l,2-cyclohexanediammonium tartrate may be prepared in advance by reaction of tr ⁇ ws- 1,2-cyclohexanediamine with L(+)-tartaric acid, wherein it is not necessary to convert the said product to traws-/-l,2-cyclohexanediamine by an otherwise difficult process which is very sensitive to the presence of even trace amounts of the air (decomposition of the tartrate, extraction of the liberated free diamine by an organic solvent, removal thereof by distillation and distillation of trans-l-l,2-cyclo- hexanediamine in vacuo ).
  • the trans-/- 1,2-cyclohexanediarnmonium tartrate may, prior to the reaction with alkali metal tetrachloroplatinate(II) , be made free from present insoluble impurities by such a way that its aqueous suspension is made alkaline by an alkali metal hydroxide to pH value of at least 8 and the obtained solution is brought into the reaction after separation of impurities.
  • Another advantage of the process for production of c/s-dichloro-(traws-/-l,2-cyclo- hexanediamine)platinum(II) according to the invention is based on the possibility to use a raw solution of potassium tetrachloroplatinate(II) obtained by reduction of potassium hexachloroplatinate(IV) with hydrazinium dichloride, removing insoluble matter and neutralisation of free hydrochloric acid by an alkali metal hydroxide, in the place of the solution of an alkali metal tetrachloroplatinate(II).
  • pH value of the reaction mixture was maintained at 9.5-10.0 by addition of approx. 2M solution of potassium hydroxide via a peristaltic pump.
  • the yield was 58.1 g of c s-dichloro-(tr ns-/-l,2-cyclohexanediamine)platinum(II), i.e. 97.6% of theoretical yield, based on the starting potassium tetrachloroplatinate(II).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)

Abstract

A process for production of cis-dichloro-(trans-1-1,2-cyclohexanediamine)platinum(II) complex, based on treatment of 1 mol of alkali metal tetrachloroplatinate(II) in an aqueous solution with 0.9 to 1.7 mol of trans-1-1,2-cyclohexanediammonium tartrate at pH of the reaction mixture between 7 and 12 obtained by alkalinisation by an alkali metal hydroxide, followed by separation of the solid product from the aqueous reaction medium.

Description

Process for production of ris-dichloro-(trans-I-l,2-cyclohexanediamine)plati- num(H)
Field of the Invention
The invention deals with a new process for production of an antitumor effective compound c/5-dichloro-(trα«5-/-l,2-cyclohexanediamine)platinum(II) complex of the formula
Figure imgf000002_0001
which is an intermediate in the synthesis of metal-containing antitumor agent oxaliplatin, i. e. (trans-l- 1 ,2-cyclohexanediamine)-(oxalato)platinum(LT).
Background of the Invention
The c/5-dichloro-(trα«5-/-l,2-cyclohexanediamine)platinum(II) was prepared until now according to US patent No. 4,169,846, by a long-termed reaction of potassium tetrachloroplatinate(II) with tra«s-/-l,2-cyclohexanediarnine followed by recrystallization of the obtained raw product from boiling 0.1 M hydrochloric acid. This known procedure has however several basic disadvantages. One of these disadvantages is in that the starting optically active traws-/-isomer of 1,2-cyclohexanediamine is relatively expensive starting material. Other disadvantage is in that the recrystallization of the obtained raw product requires large amounts of diluted hydrochloric acid due to a low solubility of the cis-dicMoro-(trarø-/-l,2-cydohexanediarrune)platinum(II) complex and the obtained yields of this final product are relatively low. Finally, the second starting material, i.e. crystalline potassium tetrachloroplatinate(II), is rather expensive as well.
The goal of the present invention is to find a new process for preparation of the cis- dichloro-(tra«5-/-l,2-cyclohexanediamine)platinum(II) which would not suffer from the above disadvantages. Summary of the Invention
The above discussed disadvantages are not exhibited in a novel method for production of the cw-dichloro-(trαw5-/-l,2-cyclohexanediamine)platinum(II) characterised in reacting 1 molar equivalent of alkali metal salt of tetrachloroplatinate(II) in an aqueous solution with 0.9 to 1.7 molar equivalents of trans-l-l,2-cyclo- hexanediammonium tartrate at a pH value of the reaction medium between 7 and 12 that has been obtained by alkalinization thereof by an alkali metal hydroxide, followed by separation of the solid product from the aqueous reaction medium. In a particularly advantageous embodiment of the process of the invention, 1 molar equivalent of an alkali metal salt of tetrachloroplatinate(II) is treated with 1.1 to 1.3 molar equivalents of tr «5-/-l,2-cyclohexanediammonium tartrate. Advantageously, the alkalinity of the reaction mixture is maintained during the reaction by additions of an alkali metal hydroxide within the pH range from 8 to 11. In a preferred embodiment, the aqueous suspension of trø«s-/-l,2-cyclohexanediammonium tartrate is first alkalinized by an alkali metal hydroxide to a pH value higher than 8 and , prior to mixing with the aqueous solution of alkali metal tetrachloroplatinate(II), the obtained solution is separated from insoluble impurities present. As the aqueous solution of an alkali metal tetrachloroplatinate(II), a raw aqueous solution of potassium tetrachloroplatinate(II) obtained by reduction of potassium hexachloroplatinate(IV) by hydrazinium dichloride, separation of insoluble parts and neutralisation of the free hydrochloric acid present in the obtained aqueous solution by an alkali metal hydroxide, may advantageously be used . The process of the invention proceeds according the following reaction scheme : M2PtCU + C6H10( H3)2C4H4O6 + 2 MOH --> [PtCl2[C6H10(NH2)2]] +
Figure imgf000003_0001
+ 2 MCI + 2 H2O wherein M means an alkali metal.
Reaction temperature is not a critical parameter within the process of the invention. The obtained c/s-dicMoro-(trα«s-/-l,2-cyclohexanediamine)platinum(II) may be separated from the reaction mixture by standard separation techniques, washed with a diluted hydrochloric acid and/or by water and/or by a water miscible organic solvent, advantageously by a low boiling alcohol, and optionally also by ether, and subsequently dried.
The optically active trα«5-/-l,2-cyclohexanediammonium tartrate may be prepared in advance by reaction of trαws- 1,2-cyclohexanediamine with L(+)-tartaric acid, wherein it is not necessary to convert the said product to traws-/-l,2-cyclohexanediamine by an otherwise difficult process which is very sensitive to the presence of even trace amounts of the air (decomposition of the tartrate, extraction of the liberated free diamine by an organic solvent, removal thereof by distillation and distillation of trans-l-l,2-cyclo- hexanediamine in vacuo ). By using a slight excess of trans-/- 1,2-cyclohexanediammonium tartrate, one may obtain almost theoretical consumption of alkali metal tetrachloroplatinate(H) which is the most expensive part of the whole system, whereby eventual losses are mainly the losses during manipulation. Furthermore, one of the advantages of the process for preparation of c/s-dichloro-(tra«s- /-l,2-cyclohexanediamine)platinum(II) according to the invention is a possibility of continual maintaining of the proper alkalinity of the reaction medium by addition of an alkali metal hydroxide at approximately constant value of pH, advantageously in a pH range between 8 and 11. Thereby, formation of both reaction by-products and impurities is minimised. The termination of the reaction is indicated by the fact that the pH of the reaction system does not drop and maintains steady in the absence of addition of the alkali metal hydroxide.
The trans-/- 1,2-cyclohexanediarnmonium tartrate may, prior to the reaction with alkali metal tetrachloroplatinate(II) , be made free from present insoluble impurities by such a way that its aqueous suspension is made alkaline by an alkali metal hydroxide to pH value of at least 8 and the obtained solution is brought into the reaction after separation of impurities.
Another advantage of the process for production of c/s-dichloro-(traws-/-l,2-cyclo- hexanediamine)platinum(II) according to the invention is based on the possibility to use a raw solution of potassium tetrachloroplatinate(II) obtained by reduction of potassium hexachloroplatinate(IV) with hydrazinium dichloride, removing insoluble matter and neutralisation of free hydrochloric acid by an alkali metal hydroxide, in the place of the solution of an alkali metal tetrachloroplatinate(II). This way, one may avoid a necessity of preparation of a crystalline potassium tetrachloroplatinate(II) requiring concentration of large volumes of a solution of potassium tetrachloroplatinate(π) containing considerably high amounts of free hydrochloric acid and precipitation of the product by concentrated hydrochloric acid, which is difficult and risky as far as exhalations are concerned.
In the next part of the disclosure, the invention will be further illustrated by means of more concrete examples of its embodiment, whereby these examples are of illustrative character only and they by no way limit the scope of the invention which is unambiguously defined by patent claims. Within the examples, the unit operations were performed, whenever necessary or possible, under limited access of air and the used water was purged with nitrogen prior its use.
Examples of the Invention
Example 1
1084.6 g of an intermediate from production of c/'s-diammin-dichloroplatinum(π) represented by an aqueous solution containing lOO.Og of potassium tetrachloroplatinate(II) , was allowed to stand for three days at 5°C. The precipitated part of unreacted potassium hexachloroplatinate(IV) was filtered off. Strongly acidic filtrate was charged into a 2 liter vessel equipped by a stirrer, combined pH-electrode, nitrogen inlet and inlet for reactants, and was neutralised by an aqueous solution (approx. 2 M) of potassium hydroxide to pH = 5.7. The adjusted solution was mixed with a second solution prepared by suspending of 73.5 g of pre-made trans-l-l,2-cyclo- hexanediammonium tartrate in 600 ml water, alkalinisation to pH = 8.3 by potassium hydroxide solution of the above concentration, and filtration. In further, pH value of the reaction mixture was maintained at 9.5-10.0 by addition of approx. 2M solution of potassium hydroxide via a peristaltic pump. After 10 hours of stirring , when the pH value was constant, the formed c/s-dichloro-(traws-/-l,2-cyclohexane- diamine)platinum(II) was filtered off, washed with demineralised water, ethanol and ether and dried in vacuum oven to constant weight. The yield was 89.0g of c/s-dichloro-(tra«s-/-l,2-cyclohexanediamine)platinum(II) i.e. 97.3% of theory, based on the content of potassium tetrachloroplatinate(II) in the starting material.
Example 2
47.6 g of pre-made trans-l- 1,2-cyclohexanediammonium tartrate was suspended in 400 ml of water and the pH value was adjusted to 8.15 by the aid of an aqueous solution of potassium hydroxide ( approx. 2M) . The obtained solution was filtered and charged together with 65.0 g of crystalline potassium tetrachloroplatinate(II) into 1 liter vessel equipped by a stirrer, combined pH-electrode, nitrogen inlet and inlet of potassium hydroxide. The pH value of the reaction mixture was kept at a value of approx. 10 by additions of potassium hydroxide solution of the above concentration. The formed cis- dichloro-(trαns-/-l,2-cyclohexanediamine)platinum(π) was filtered off, washed with water, diluted hydrochloric acid ( 0.3 M HC1), ethanol and ether and dried in vacuum oven to constant weight.
The yield was 58.1 g of c s-dichloro-(tr ns-/-l,2-cyclohexanediamine)platinum(II), i.e. 97.6% of theoretical yield, based on the starting potassium tetrachloroplatinate(II).

Claims

1. A process for preparation of a cts-dichloro-(trcms-/-l,2-cyclo- hexanediamino)platinum(II) characterised by treating 1 mol of an alkali metal tetrachloroplatinate(II) with 0.9 to 1.7 mol of trans-l- 1,2-cyclohexanediammonium tartrate in an aqueous solution at a pH value of the reaction mixture between 7-12 obtained by alkalinization thereof by an alkali metal hydroxide , followed by separation of the solid product from the aqueous reaction medium.
2. The process according to claim 1 characterised by treating 1 mol of alkali metal tetrachloroplatinate(II) with 1.1 to 1.3 mol of trans-l- 1,2-cyclohexanediammonium tartrate.
3. The process according to claim 1 characterised in that the alkaline value of the reaction mixture is maintained within the course of the reaction by additions of an alkali metal hydroxide at a pH value of from 8 to 11.
4. The process according to claim 1 characterised in that an aqueous suspension of trans-l- 1,2-cyclohexanediammonium tartrate is first made alkaline by an alkali metal hydroxide to a pH value of at least 8 and the obtained solution is separated from present insoluble impurities prior to mixing with the aqueous solution of alkali metal tetrachloroplatinate(II) .
5. The process according to claim 1 characterised by using, as the aqueous solution of alkali metal tetrachloroplatinate (LT), a raw aqueous solution of potassium tetrachloroplatinate(II) obtained by reduction of an aqueous solution of hexachloroplatinate(rV) with hydrazinium dichloride , separation of insoluble matter and neutralisation of the free hydrochloric acid in the obtained aqueous solution by an alkali metal hydroxide.
PCT/CZ2000/000070 1999-09-29 2000-09-22 Process for production of cis-dichloro-(trans-1-1,2-cyclohexanediamine)platinum(ii) WO2001022915A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU72673/00A AU7267300A (en) 1999-09-29 2000-09-22 Process for production of cis-dichloro-(trans-1-1,2-cyclohexanediamine)platinum(ii)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZPV1999-3458 1999-09-29
CZ19993458A CZ294382B6 (en) 1999-09-29 1999-09-29 Process for preparing cis-dichloro-(trans-l-1,2-cyclohexanediamine)platinum complex

Publications (2)

Publication Number Publication Date
WO2001022915A2 true WO2001022915A2 (en) 2001-04-05
WO2001022915A3 WO2001022915A3 (en) 2001-10-25

Family

ID=5466775

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CZ2000/000070 WO2001022915A2 (en) 1999-09-29 2000-09-22 Process for production of cis-dichloro-(trans-1-1,2-cyclohexanediamine)platinum(ii)

Country Status (3)

Country Link
AU (1) AU7267300A (en)
CZ (1) CZ294382B6 (en)
WO (1) WO2001022915A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104940151A (en) * 2015-07-23 2015-09-30 青岛蓝盛洋医药生物科技有限责任公司 Oxaliplatin freeze-dried powder injection composition as anti-cancer drug
CN104945443A (en) * 2015-07-23 2015-09-30 青岛蓝盛洋医药生物科技有限责任公司 Drug, namely oxaliplatin compound, for treating cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558469B1 (en) * 1984-01-25 1986-06-27 Bellon Labor Sa Roger NOVEL PLATINUM COORDINATION COMPOUNDS, METHODS OF MAKING SAME AND THEIR USE AS MEDICAMENTS
IL74449A (en) * 1984-03-01 1988-07-31 Us Commerce Tetrahalo-1,2-cyclohexane-diamino platinum complexes and anti-neoplastic compositions comprising them
US4658047A (en) * 1985-09-27 1987-04-14 The United States Of America As Represented By The Department Of Health And Human Services Method of preparing 1,2-diaminocyclohexane tetrachloro platinum (IV) isomers
JP2820289B2 (en) * 1989-10-13 1998-11-05 田中貴金属工業株式会社 Method for producing potassium tetrachloroplatinate

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104940151A (en) * 2015-07-23 2015-09-30 青岛蓝盛洋医药生物科技有限责任公司 Oxaliplatin freeze-dried powder injection composition as anti-cancer drug
CN104945443A (en) * 2015-07-23 2015-09-30 青岛蓝盛洋医药生物科技有限责任公司 Drug, namely oxaliplatin compound, for treating cancer

Also Published As

Publication number Publication date
WO2001022915A3 (en) 2001-10-25
AU7267300A (en) 2001-04-30
CZ9903458A3 (en) 2001-05-16
CZ294382B6 (en) 2004-12-15

Similar Documents

Publication Publication Date Title
US7956208B2 (en) Preparation of platinum (II) complexes
US7888523B2 (en) Preparation of platinum(II) complexes
CN100408588C (en) Oxaliplatin with low content of associated impurities and preparation method thereof
US7888390B2 (en) Preparation of platinum(II) complexes
JPH09278785A (en) Method for producing platinum compound
WO2001022915A2 (en) Process for production of cis-dichloro-(trans-1-1,2-cyclohexanediamine)platinum(ii)
US7208616B2 (en) Cis-diiodo-(trans-L-1,2-cyclohexanediamine) platinum (II) complex and processes for preparing high purity oxaliplatin
JP3859093B2 (en) Method for producing antitumor platinum complex carboplatin
JP4568400B2 (en) Method for producing 5,5'-bi-1H-tetrazole diammonium salt using hydrated hydrazine and dicyan as raw materials
RU2186068C2 (en) Method of purification of cis-dichloroamminiso-propylaminplatinum (ii)
RU2457838C1 (en) Method of obtaining trans-1,2-diaminocyclohexane tetrachloroplatinum (iv)
JPH0725539B2 (en) Method for producing dicyanamide metal salt
US4800072A (en) Anhydrous cerous nitrate-ammonium nitrate complex and a process for its preparation from ceric ammonium nitrate
US20020099159A1 (en) Method of synthesizing complexes of platinum and alkenylpolysiloxane, especially of platinum and divinyltetramethyldisiloxane
HU199478B (en) Process for producing 1-square brackets open amino-iso (benzofuranonyl) square brackets closed isoquinoline derivatives
JP2537204B2 (en) Method for producing hydantoins
JPH07278120A (en) Process for producing 5-formylamino-pyrimidine
KR100197112B1 (en) Process for the prepararing tetrahydro amino acridine and their hydrocloride salts
JPH0827151A (en) Pudding manufacturing method
JPS62258340A (en) Production of solid disodium p-hydroxybenzoate
HU211283A9 (en) Highly pure amidoximes
JP2002105068A (en) Method for producing sulfoalkylating agent
JPS61165387A (en) Production of aminated phthalide-quinoline compound
JPS61233685A (en) Production of aminated phthalide-isoquinoline

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP